Cargando…

Antimicrobial resistance among GLASS priority pathogens from Pakistan: 2006–2018

BACKGROUND: In 2018 Pakistan initiated its national antimicrobial resistance (AMR) surveillance aligned with Global Antimicrobial Surveillance System (GLASS). To complement this surveillance, we conducted a situational analysis of AMR rates among GLASS organisms in the country. Data from published s...

Descripción completa

Detalles Bibliográficos
Autores principales: Saeed, Dania Khalid, Farooqi, Joveria, Shakoor, Sadia, Hasan, Rumina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8650393/
https://www.ncbi.nlm.nih.gov/pubmed/34876041
http://dx.doi.org/10.1186/s12879-021-06795-0
_version_ 1784611191360847872
author Saeed, Dania Khalid
Farooqi, Joveria
Shakoor, Sadia
Hasan, Rumina
author_facet Saeed, Dania Khalid
Farooqi, Joveria
Shakoor, Sadia
Hasan, Rumina
author_sort Saeed, Dania Khalid
collection PubMed
description BACKGROUND: In 2018 Pakistan initiated its national antimicrobial resistance (AMR) surveillance aligned with Global Antimicrobial Surveillance System (GLASS). To complement this surveillance, we conducted a situational analysis of AMR rates among GLASS organisms in the country. Data from published studies and from antibiograms was compared and role of antibiograms as potential contributors to national AMR surveillance explored. METHODS: AMR rates for GLASS specified pathogen/antimicrobials combination from Pakistan were reviewed. Data sources included published studies (2006–2018) providing AMR rates from Pakistan (n = 54) as well as antibiograms (2011–2018) available on the Pakistan Antimicrobial Resistance Network (PARN) website. Resistance rates were categorized as follows: Very low: 0–10%, Low: 11–30%, Moderate: 30–50% and High: > 50%. RESULTS: Published data from hospital and community/laboratory-based studies report resistance rates of > 50% and 30–50% respectively to 3rd generation cephalosporins, fluoroquinolones and cotrimoxazole amongst Klebsiella pneumoniae and Escherichia coli. Carbapenem resistance rates amongst these organisms remained below 30%. High (> 50%) resistance was reported in Acinetobacter species to aminoglycosides and carbapenems among hospitalized patients. The evolution of ceftriaxone resistant Salmonella Typhi and Shigella species is reported. The data showed > 50% to fluoroquinolones amongst Neisseria gonorrhoeae and the spread of methicillin resistant Staphylococcus aureus (< 30%; 2008) to (> 50%; 2010) in hospital settings. Resistance reported in published studies aligned well with antibiogram data. The latter also captured a clear picture of evolution of resistance over the study period. CONCLUSION: Both published studies as well antibiograms suggest high rates of AMR in Pakistan. Antibiogram data demonstrating steady increase in AMR highlight its potential role towards supplementing national AMR surveillance efforts particularly in settings where reach of national surveillance may be limited. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12879-021-06795-0.
format Online
Article
Text
id pubmed-8650393
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-86503932021-12-07 Antimicrobial resistance among GLASS priority pathogens from Pakistan: 2006–2018 Saeed, Dania Khalid Farooqi, Joveria Shakoor, Sadia Hasan, Rumina BMC Infect Dis Research BACKGROUND: In 2018 Pakistan initiated its national antimicrobial resistance (AMR) surveillance aligned with Global Antimicrobial Surveillance System (GLASS). To complement this surveillance, we conducted a situational analysis of AMR rates among GLASS organisms in the country. Data from published studies and from antibiograms was compared and role of antibiograms as potential contributors to national AMR surveillance explored. METHODS: AMR rates for GLASS specified pathogen/antimicrobials combination from Pakistan were reviewed. Data sources included published studies (2006–2018) providing AMR rates from Pakistan (n = 54) as well as antibiograms (2011–2018) available on the Pakistan Antimicrobial Resistance Network (PARN) website. Resistance rates were categorized as follows: Very low: 0–10%, Low: 11–30%, Moderate: 30–50% and High: > 50%. RESULTS: Published data from hospital and community/laboratory-based studies report resistance rates of > 50% and 30–50% respectively to 3rd generation cephalosporins, fluoroquinolones and cotrimoxazole amongst Klebsiella pneumoniae and Escherichia coli. Carbapenem resistance rates amongst these organisms remained below 30%. High (> 50%) resistance was reported in Acinetobacter species to aminoglycosides and carbapenems among hospitalized patients. The evolution of ceftriaxone resistant Salmonella Typhi and Shigella species is reported. The data showed > 50% to fluoroquinolones amongst Neisseria gonorrhoeae and the spread of methicillin resistant Staphylococcus aureus (< 30%; 2008) to (> 50%; 2010) in hospital settings. Resistance reported in published studies aligned well with antibiogram data. The latter also captured a clear picture of evolution of resistance over the study period. CONCLUSION: Both published studies as well antibiograms suggest high rates of AMR in Pakistan. Antibiogram data demonstrating steady increase in AMR highlight its potential role towards supplementing national AMR surveillance efforts particularly in settings where reach of national surveillance may be limited. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12879-021-06795-0. BioMed Central 2021-12-07 /pmc/articles/PMC8650393/ /pubmed/34876041 http://dx.doi.org/10.1186/s12879-021-06795-0 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Saeed, Dania Khalid
Farooqi, Joveria
Shakoor, Sadia
Hasan, Rumina
Antimicrobial resistance among GLASS priority pathogens from Pakistan: 2006–2018
title Antimicrobial resistance among GLASS priority pathogens from Pakistan: 2006–2018
title_full Antimicrobial resistance among GLASS priority pathogens from Pakistan: 2006–2018
title_fullStr Antimicrobial resistance among GLASS priority pathogens from Pakistan: 2006–2018
title_full_unstemmed Antimicrobial resistance among GLASS priority pathogens from Pakistan: 2006–2018
title_short Antimicrobial resistance among GLASS priority pathogens from Pakistan: 2006–2018
title_sort antimicrobial resistance among glass priority pathogens from pakistan: 2006–2018
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8650393/
https://www.ncbi.nlm.nih.gov/pubmed/34876041
http://dx.doi.org/10.1186/s12879-021-06795-0
work_keys_str_mv AT saeeddaniakhalid antimicrobialresistanceamongglassprioritypathogensfrompakistan20062018
AT farooqijoveria antimicrobialresistanceamongglassprioritypathogensfrompakistan20062018
AT shakoorsadia antimicrobialresistanceamongglassprioritypathogensfrompakistan20062018
AT hasanrumina antimicrobialresistanceamongglassprioritypathogensfrompakistan20062018